Devaki Shilpa Surasi

Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)

Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer et al. · European Urology · 2023 · 86 citations · Full text

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Nathaniel R. Wilson, Andrew James Wiele, Devaki Shilpa Surasi et al. · Clinical Genitourinary Cancer · 2021 · 34 citations · Full text

Urology, Oncology, Genitourinary Cancer +7

Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma

Andrew James Wiele, Devaki Shilpa Surasi, Priya Rao et al. · Cancers · 2021 · 32 citations · Full text

Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies

Daniel D. Shapiro, Melinda Soeung, Luigi Perelli et al. · Cancers · 2021 · 28 citations · Full text

Physical Activity, Military Service, Renal Medullary Carcinoma +20

The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance

Justin R. Gregg, Devaki Shilpa Surasi, Alexandria Childs et al. · The Journal of Urology · 2020 · 25 citations · Full text